Nakamoto Inc., formerly known as Kindly MD, Inc., has formally rebranded its corporate identity. On January 16, 2026, the company filed a Certificate of Amendment in Delaware to change its name to Nakamoto Inc., effective January 21, 2026, and updated its principal office address to 300 10th Ave South, Nashville, TN 37203. The board also approved amended and restated bylaws to reflect the new name, with no other bylaw changes. The company’s common stock will continue trading on the Nasdaq Global Market under the symbol NAKA, and its tradeable warrants will continue to be quoted on the OTC Pink Market under the symbol NAKAW. Existing shareholders do not need to take any action as a result of this rebranding.
Kindly MD, Inc. reported that on September 15, 2025 it sent a redemption notice to the holder of its Secured Convertible Debenture dated August 15, 2025. The company plans to redeem on September 29, 2025 all amounts under the debenture that have not been converted by that date, paying cash equal to 100% of the outstanding principal plus a 1.5% payment premium, with payment to be delivered on September 30, 2025. If the holder does not convert any portion of the debenture, the total cash redemption amount including the 1.5% premium would be $203,000,000, and there will be no accrued or unpaid interest due as of the redemption date.
Kindly MD, Inc. discloses material risks and shareholder details in this S-3ASR filing. The company warns that costs and potential litigation related to a proposed Merger have been and will be incurred, that trading of its securities may be volatile, and that shareholders may face dilution from warrant exercises and future equity issuances. The filing highlights industry-specific regulatory risk for medical cannabis, competitive and technology threats, reliance on key management, and cybersecurity concerns. Significant beneficial ownership stakes are shown, including a holder with 133,928,571 shares (27.19%) and another with 114,246,002 shares (23.94%), and a large block totaling 53,571,429 shares (13.57%). The registrant describes permitted distribution methods for registered shares and undertakes post-effective filing obligations. The document includes officer and director signatures certifying the filing.
Kindly MD, Inc. filed an S-8 registration to register share awards under its employee plans. The filing references the Kindly MD, Inc. 2022 Equity Incentive Plan (incorporated by reference) and files the 2025 Equity Incentive Plan on Form S-8, includes corporate charter and bylaw exhibits, legal opinions and auditor consents, and standard indemnification terms for directors and officers.
Kindly MD, Inc. filed an amended Current Report (Form 8-K/A) that attaches exhibit-level disclosures for Nakamoto Holdings, Inc. The filing identifies the company's trading symbols as NAKA on The Nasdaq Stock Market LLC and NAKAW on the OTC Pink Market. It includes the consent of Wolf & Company, P.C., audited financial statements of Nakamoto as of April 30, 2025 and for the period from March 6, 2025 (inception) to April 30, 2025, unaudited financials as of June 30, 2025, unaudited pro forma condensed combined financial statements reflecting the acquisition of Nakamoto, supplemental risk factors, and management discussion and analysis for the stated periods. The filing is executed by CEO David Bailey.